Company news

Virbac SA news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

2026 third quarter consolidated sales

October 19, 2026

VIRBAC: Solid growth of +7.9% at CERS in YTD September 2026, fueled by double-digit growth of our Supercharge platforms

October 19, 2026

VIRBAC: Solid growth of +7.9% at CERS in YTD September 2026, fueled by double-digit growth of our Supercharge platforms

October 18, 2026

Declaration of the number of shares et voting rights 09/2026

October 6, 2026

Evolution of the Virbac Board of Directors

September 28, 2026

VIRBAC: A robust adjusted EBIT margin² of 18.8%, driven by solid organic revenue growth of 7.4%

September 17, 2026

Virbac rapport semestriel 2026

September 16, 2026

Nominate a Deserving Organization: Virbac Recognizes Animal Charities Through Every Pet Project

September 9, 2026

Declaration of the number of shares and voting rights 08/2026

September 7, 2026

Déclaration d'actions et de droits de vote 08/2026

September 6, 2026

Virbac: Solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge platforms

July 20, 2026

Virbac: solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge4 platforms

July 20, 2026

Virbac: croissance solide de +7,4 % à PCC au premier semestre 2026, portée par la hausse à deux chiffres de nos plateformes Supercharge⁴

July 19, 2026

Public release of Virbac Annual Report at 31 December 2025.

April 27, 2026

Leading with Care: Virbac Becomes a Human-Animal Bond Certified Company

April 22, 2026

Swine health: Virbac signs agreement with MACSO

April 17, 2026

Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms

April 16, 2026

Declaration of the number of shares and voting rights 03/2026

April 7, 2026

2025 full-year results

March 18, 2026

Virbac: 2025 annual results

March 17, 2026

Virbac recognized as "2026 Industry ESG Leader"

March 16, 2026

Declaration of the number of shares and voting rights 02/2026

March 10, 2026

Declaration of the number of shares and voting rights 01/2026

February 5, 2026

Virbac: solid 2025 dynamic with annual revenue up +7.9% at CERS3; with strong momentum in key categories and countries

January 19, 2026

Declaration of the number of shares and voting rights 12/2025

January 9, 2026

VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm

December 16, 2025

Declaration of the number of shares and voting rights 11/2025

December 8, 2025

Declaration of the number of shares and voting rights 10/2025

November 7, 2025

VIRBAC Announces Third Quarter 2025 Sales

October 16, 2025

Next-generation collar for long-lasting parasite protection in cats and dogs

October 14, 2025

Declaration of the number of shares and voting rights 09/2025

October 3, 2025

Virbac introduces world-first medicated feed for cats

September 24, 2025

Virbac: 2025 Half-year results

September 12, 2025

Declaration of the number of shares and voting rights 08/2025

September 5, 2025

Declaration of the number of shares and voting rights 07/2025

September 5, 2025

Virbac: : Paul Martingell's compensation terms

August 18, 2025

Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation

July 16, 2025

Declaration of the number of shares and voting rights 06/2025

July 4, 2025

VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025

June 19, 2025

Declaration of the number of share and voting rights 05/2025

June 10, 2025

Declaration of the number of shares and voting rights 04/2025

May 7, 2025

Decks

The 5 newest of 10 decks. Every deck is listed under its year.